JPWO2019183333A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019183333A5
JPWO2019183333A5 JP2020550648A JP2020550648A JPWO2019183333A5 JP WO2019183333 A5 JPWO2019183333 A5 JP WO2019183333A5 JP 2020550648 A JP2020550648 A JP 2020550648A JP 2020550648 A JP2020550648 A JP 2020550648A JP WO2019183333 A5 JPWO2019183333 A5 JP WO2019183333A5
Authority
JP
Japan
Prior art keywords
disease
composition
composition according
subject
auc last
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020550648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021518392A5 (https=
JP2021518392A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/023338 external-priority patent/WO2019183333A1/en
Publication of JP2021518392A publication Critical patent/JP2021518392A/ja
Publication of JP2021518392A5 publication Critical patent/JP2021518392A5/ja
Publication of JPWO2019183333A5 publication Critical patent/JPWO2019183333A5/ja
Pending legal-status Critical Current

Links

JP2020550648A 2018-03-22 2019-03-21 二官能性血液脳治療 Pending JP2021518392A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862646845P 2018-03-22 2018-03-22
US62/646,845 2018-03-22
PCT/US2019/023338 WO2019183333A1 (en) 2018-03-22 2019-03-21 Bifunctional blood brain therapies

Publications (3)

Publication Number Publication Date
JP2021518392A JP2021518392A (ja) 2021-08-02
JP2021518392A5 JP2021518392A5 (https=) 2022-03-28
JPWO2019183333A5 true JPWO2019183333A5 (https=) 2022-03-28

Family

ID=67986347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020550648A Pending JP2021518392A (ja) 2018-03-22 2019-03-21 二官能性血液脳治療

Country Status (9)

Country Link
US (1) US20210046149A1 (https=)
EP (1) EP3818077A4 (https=)
JP (1) JP2021518392A (https=)
KR (1) KR20210004995A (https=)
CN (1) CN112292393A (https=)
AU (1) AU2019240218A1 (https=)
CA (1) CA3094179A1 (https=)
IL (1) IL277395A (https=)
WO (1) WO2019183333A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102905380B1 (ko) 2019-07-26 2025-12-30 뒤센펠드 게엠베하 리튬 배터리를 재활용하는 방법
US20210355468A1 (en) * 2020-05-18 2021-11-18 Bioasis Technologies, Inc. Compositions and methods for treating lewy body dementia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2582869T3 (es) * 2011-07-05 2016-09-15 Bioasis Technologies Inc Conjugados de P97-anticuerpo
JP6586412B2 (ja) * 2013-03-13 2019-10-02 バイオアシス テクノロジーズ インコーポレイテッド p97のフラグメントおよびその使用

Similar Documents

Publication Publication Date Title
JP2025128190A5 (https=)
US5616321A (en) Method of treating bacterial meningitis with anti-tumor necrosis factor antibody
US8557546B2 (en) Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseases
CN103079586B (zh) G‑csf二聚体在治疗嗜中性粒细胞减少症中的应用
JP2021514354A5 (https=)
JP2025122021A5 (https=)
JP2007500741A (ja) 一時的処置のための短い半減期を有するc1インヒビター
US8956605B2 (en) Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
JP2021518392A5 (https=)
US7947283B2 (en) Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides
JPWO2019183333A5 (https=)
CN108939074A (zh) 治疗再生障碍性贫血的方法和药物组合物
CN109232744B (zh) 改进型齐考诺肽
JPWO2020055812A5 (https=)
JPWO2021148411A5 (https=)
JPWO2022026902A5 (https=)
CN108853483B (zh) 经修饰的胸腺素β4在治疗脑缺血再灌注损伤方面的用途
JP2002529515A5 (https=)
CA2201841A1 (en) Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
WO2007041964A1 (fr) Utilisation de recepteur long du facteur de necrose tumorale alpha soluble recombinant humain de demi-vie dans la preparation de medicament pouvant prevenir l'insuffisance hepatique
CN103788179B (zh) 多肽小分子及其在制备防治膀胱过度活跃药物中的应用
WO2024199436A1 (zh) 具有延长的半衰期和提高的稳定性的多肽活性分子
AU755240B2 (en) Treatment of neurological conditions by an interleukin-1 inhibiting compound
JP2021524858A5 (https=)
JPWO2020245676A5 (https=)